Life Sciences Funding in Europe (2006)- Phase I

 

USD 4,950

* Required Fields

USD 4,950

PAY BY INVOICE

Be the first to review this product

The research service provides the sources of life sciences funding in Europe with specific funding analysis of Germany, UK, France, Scandinavia and Spain. Denmark, Finland, Norway and Sweden are included in Scandinavia.

Table of Contents

Life Sciences Funding in Europe (2006)- Phase I, Executive SummaryOverview of the Life Sciences Funding in EuropeExecutive Summary of the Life Sciences Funding in EuropeLife Sciences Funding in Europe (2006)- Phase I, GlossaryGlossary of TermsTerminologiesKey AcronymsAcronymsLife Sciences Funding in Europe (2006)- Phase I, Assumptions and MethodologyResearch Scope and MethodologyResearch Scope and SegmentationLife Sciences Funding in Europe (2006)- Phase I, Funding in EuropeFunding LandscapeFunding ScenarioEuropean Funding OverviewEuropean Funding ChallengesMarket Engineering MeasurementsFunding AnalysisLife Sciences Funding in Europe (2006)- Phase I, Funding in the United KingdomFunding OverviewOverviewMarket Engineering MeasurementsMarket Engineering ResearchFunding ScenarioFunding AnalysisLife Sciences Funding in Europe (2006)- Phase I, Funding in GermanyFunding OverviewOverviewMarket Engineering MeasurementsMarket Engineering ResearchFunding ScenarioFunding AnalysisLife Sciences Funding in Europe (2006)- Phase I, Funding in FranceFunding OverviewOverviewMarket Engineering MeasurementsMarket Engineering ResearchFunding ScenarioFunding AnalysisLife Sciences Funding in Europe (2006)- Phase I, Funding in DenmarkFunding OverviewOverviewMarket Engineering MeasurementsMarket Engineering ResearchFunding ScenarioFunding AnalysisLife Sciences Funding in Europe (2006)- Phase I, Funding in FinlandFunding OverviewOverviewMarket Engineering MeasurementsMarket Engineering ResearchFunding ScenarioFunding AnalysisLife Sciences Funding in Europe (2006)- Phase I, Funding in NorwayFunding OverviewOverviewMarket Engineering MeasurementsMarket Engineering ResearchFunding ScenarioFunding AnalysisLife Sciences Funding in Europe (2006)- Phase I, Funding in SwedenFunding OverviewOverviewMarket Engineering MeasurementsMarket Engineering ResearchFunding ScenarioFunding AnalysisLife Sciences Funding in Europe (2006)- Phase I, Funding in SpainFunding OverviewOverviewMarket Engineering MeasurementsMarket Engineering ResearchFunding ScenarioFunding AnalysisLife Sciences Funding in Europe (2006)- Phase I, Decision Support DatabaseDatabase TablesBiotech CompaniesBiotech Private InvestmentPer cent of Government Investment in BiotechnologyGovernment Biotech R&D InvestmentEnrollment of Students




Keyword1

Keyword2

Keyword3

Related Research

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.